Both in Lab Analytical Instruments
Pacific Biosciences of California vs 10x Genomics
Over the past year PACB returned +8.9% and TXG returned +376.6%; their daily moves had a correlation of 0.53.
PACB +8.9% TXG +376.6%Growth of $1, one year, split-adjusted
| Metric | PACB | TXG |
|---|---|---|
| Price | $2.44 | $65.29 |
| Market cap | $758.4M | $8.51B |
| Today | +4.05% | +5.94% |
| 1 month | −15.0% | −33.2% |
| 6 months | +54.4% | +196.6% |
| Year to date | +30.5% | +300.3% |
| 1 year | +4.3% | +378.7% |
| Revenue growth (YoY) | −1.9% | −12.6% |
| Gross margin | 32.4% | 74.5% |
| Net margin | −114.7% | −11.9% |
| P/E (TTM) | — | — |
| Price / sales | 4.8× | 13.8× |
| Net cash | -$407.5M | $552.0M |
| Dividend yield | — | — |
| Volatility (60d) | 116.6% | 85.7% |
| Short % of float | 18.2% | 10.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).